Greenphire Celebrates 1 Million Payments

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

January 17, 2014 -- Greenphire, the leading provider of payment technology for the clinical trials industry, today announced a significant milestone: it has officially executed one million payments through its clinical payment platform. With a client base that grew by over 140% in 2013 alone, the company credits the industry’s adoption of automated clinical payment processes to its platform’s unrivalled ability to significantly reduce the administrative processes, costs, and risks associated with manual processing of payments while simultaneously increasing site satisfaction, patient retention, and access to analytics and reporting.

“This milestone is a real indication of the industry’s embrace of technology to streamline clinical trial payment processes,"; commented Sam Whitaker, CEO. “As one of Greenphire’s founders, I am tremendously excited and humbled to see such a positive, concrete measure of our growth and I look forward to an exciting year ahead.”

“Based on current trends, we anticipate making an additional million payments or more in 2014,” said Chief Technology Officer David Wallace, “meaning we’ll make more payments in 2014 than we have since Greenphire’s inception! This is exciting for our business, and it proves that our infrastructure is scalable and will meet the needs of our customer base as it continues to grow exponentially.”

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC